| scholarly article | Q13442814 |
| P50 | author | Mark J Ratain | Q87725760 |
| Wanqing Liu | Q40121377 | ||
| P2093 | author name string | Lijun He | |
| Jacqueline Ramírez | |||
| P2860 | cites work | A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans | Q40490424 |
| Clinical implications of the p53 gene | Q41036383 | ||
| Mdm2 promotes genetic instability and transformation independent of p53. | Q41337111 | ||
| Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study | Q46465639 | ||
| Incidence and prognostic significance of MDM2 oncoprotein overexpression in relapsed childhood acute lymphoblastic leukemia | Q73359066 | ||
| Somatic mutations affect key pathways in lung adenocarcinoma | Q24648102 | ||
| Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy | Q24651380 | ||
| Comprehensive genomic characterization defines human glioblastoma genes and core pathways | Q24656128 | ||
| High levels of the MDM2 oncogene in paediatric rhabdomyosarcoma cell lines may confer multidrug resistance | Q28366242 | ||
| Cancer. Addiction to oncogenes--the Achilles heal of cancer | Q29614243 | ||
| The NCI60 human tumour cell line anticancer drug screen | Q29614975 | ||
| A gene expression database for the molecular pharmacology of cancer | Q29619242 | ||
| The MDM2 gene amplification database | Q34672224 | ||
| Cell cycle regulatory functions of the human oncoprotein MDM2. | Q35621045 | ||
| Haplotype structure and selection of the MDM2 oncogene in humans | Q35721519 | ||
| MDM2 inhibitors for cancer therapy | Q36663493 | ||
| MDMX: from bench to bedside | Q36717697 | ||
| A single nucleotide polymorphism in the p53 pathway interacts with gender, environmental stresses and tumor genetics to influence cancer in humans | Q36745377 | ||
| Mutation analysis of 24 known cancer genes in the NCI-60 cell line set. | Q37250634 | ||
| Relationship of EGFR mutations, expression, amplification, and polymorphisms to epidermal growth factor receptor inhibitors in the NCI60 cell lines | Q40050748 | ||
| Effect of a single nucleotide polymorphism in the murine double minute 2 promoter (SNP309) on the sensitivity to topoisomerase II-targeting drugs | Q40118494 | ||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemotherapy | Q974135 |
| P304 | page(s) | 7602-7607 | |
| P577 | publication date | 2009-12-01 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Interactions between MDM2 and TP53 Genetic Alterations, and Their Impact on Response to MDM2 Inhibitors and Other Chemotherapeutic Drugs in Cancer Cells | |
| P478 | volume | 15 |
| Q34768681 | A genome-wide integrative study of microRNAs in human liver |
| Q37019200 | A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival |
| Q34406172 | Allele Loss and Down-Regulation of Heparanase Gene Are Associated with the Progression and Poor Prognosis of Hepatocellular Carcinoma |
| Q90298995 | An evaluation in vitro of the efficacy of nutlin-3 and topotecan in combination with 177Lu-DOTATATE for the treatment of neuroblastoma |
| Q37738067 | An investigation of the role of gene copy number variations in sorafenib sensitivity in metastatic hepatocellular carcinoma patients |
| Q39103518 | Association between hTERT rs2736100 polymorphism and sensitivity to anti-cancer agents |
| Q33917547 | Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing |
| Q90427860 | MDM4 contributes to the increased risk of glioma susceptibility in Han Chinese population |
| Q35030217 | Targeting MDM2-p53 interaction for cancer therapy: are we there yet? |
| Q55517350 | The Roles of MDM2 and MDMX in Cancer. |
| Q37803120 | Translating p53 into the clinic. |
| Q35995829 | Whole genome sequence analysis links chromothripsis to EGFR, MDM2, MDM4, and CDK4 amplification in glioblastoma |
Search more.